Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Highly selective dopamine D4 receptor partial agonists identified at German university

Dec. 11, 2000

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

Biogen licenses novel neurotrophic protein from NsGene

Dec. 11, 2000

Neurochem demonstrates proof of concept for AD compound

Dec. 11, 2000

Copaxone launched in the U.K.

Dec. 7, 2000

NeuroSearch describes new nAChR modulators and their use

Dec. 7, 2000

NXY-059 effective in various animal models of stroke and well tolerated in acute stroke patients

Dec. 7, 2000

Xyrem NDA accepted for filing

Dec. 7, 2000

NIH-funded research leads to identification of gene related to autism

Dec. 7, 2000

Higher doses of interferon beta-1a offer no additional clinical benefit for MS patients

Dec. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...